Abstract:Objective: To analyze the use of blood products in patients at different ages. Methods: The clinical datas of the 10 784 patients transfused in Sichuan provincial people's hospital at 2017-2018 were retrospectively analyzed, and the basic condition of clinical blood using was statistically described. The patients were divided into the groups according to age and disease, then the use of various blood products in the patients with different diseases in different age groups was analyzed. Results: The age of blood transfusion patients was mainly 40-80 years old, and the most common disease was tumor(about 28%). The average annual transfusion volumes of red blood cells(RBC) were 24 936.5 U, of platelets(PLT) were 3 795 therapeutic doses of plasma were 2 455 500 ml, of cryoprecipitate were 3 461.5 U in our hospital. Most patients with hematologic malignancies and liver cirrhosis were transfused with two or more blood productions. For the patients with hematologic malignancies, the irradiated RBC (76.4%), PLT (67.8%), and suspended RBC (59.9%) were commonly used. And for liver cirrhosis patients, the suspended RBC (64.2%) and fresh frozen plasma(FFP) (59.4%) were commonly used. For the patients with trauma and chronic kidney disease(CKD), the suspended RBC (95.7% and 91.5%, respectively) was commonly used. In hematologic malignancies patients, the transfusion volume of irradiated RBC, PLT and FFP in the patients aged ≥60 years old was lower than that in patients aged<60 years old (P<0.05); in trauma patients, the transfusion volume of suspended RBC in the patients aged ≥60 years old was lower than that in patients aged<60 years old (P<0.05). In hematologic malignancies, trauma and liver cirrhosis patients, the proportion of PLT and/or plasma transfusion in the patients aged ≥60 years old was lower than that in patients aged<60 years old (P<0.05), and the elderly patients were more likely to receive RBC transfusion only. Conclusion: There is a difference in the distribution of blood product between the patients aged<60 years old and ≥60 years old in the same disease, and it is more likely that the elderly patients (aged ≥60 years old) receive RBC transfusion only, and correction of hypoxia is a major clinical consideration, so blood using plans should be made according to the patient population, moreover, the different transfusion strategies should be developed for different population to maximize the efficiency of blood using.

Study on Impact of Recipients Age on Clinical Platelets Transfusion

Platelet aggregation function in apparently healthy elderly Chinese: results from a multi-center investigation

Predictive Value of Plasma IL-1 Β, IL-8 Levels and Clinical Factors for Platelet Transfusion Refractoriness in Patients with Pediatric Cancer

Clinical Study on Renal Transplantation in Aged Recipients:A Report of 126 Cases

Analysis of the factors influencing the efficacy of platelet transfusion

Clinical Study on Part Factors Affecting the Effect of Platelet Transfusion During Hematopoietic Stem Cell Transplantation

Transfusion‐induced Platelet Antibodies and Regulatory T Cells in Multiply Transfused Patients

[Clinical Blood Utilization of Patients at Different Ages for a Hospital in Sichuan from 2017 to 2018]

Correlation analysis between platelet parameters and efficacy of platelet transfusion and prognosis

Immune Reconstitution and Survival of Patients after Allogeneic Hematopoietic Stem Cell Transplantation from Older Donors

Retrospective study of the clinical application of cryopreserved platelets transfusion during the past 8 years

Effect of age and gender on platelet reactivity in coronary heart disease patients

Impact of Donor Age on Liver Transplant Outcomes in Patients with Acute-on-Chronic Liver Failure: A Cohort Study.

Clinical current status and research progress on transfusion strategy of older patients

Blood transfusion in injured older adults: A retrospective cohort study

The disparity of platelet factor 4 and platelets in individuals of different ages

Exploration of HLA-matched Platelet Units in HLA-immunized PTR: a Retrospective Study of Patients with Hematological Disorders

Responsiveness to Platelet Transfusions in Pediatric Patients with Thrombocytopenia: Incidence, Clinical Variables

In platelet single donor apheresis, platelet factor 4 levels correlated with donor's age and decreased during storage

Improving platelet function following prophylactic platelet transfusion in patients with hematological malignancies

Analysis of Refractoriness to Platelet Transfusion in Patients with Idiopathic Thrombocytopenic Purpura